Year: 2025

Two WashU faculty are among nearly 250 newly elected members of the American Academy of Arts & Sciences, one of the nation’s most prestigious honorary societies. They are physicist Carl Bender, in Arts & Sciences, and immunologist Marco Colonna, at the School of Medicine.

A new analysis, led by WashU Medicine researchers and published in Cell Genomics, examines how certain proteins in human cells are implicated in both cancer and neurodevelopmental disorders, but behave differently, complicating potential interventions.

The WashU Empower program will receive a “What’s Right with the Region” Award from Focus St. Louis at its 28th annual celebration event May 15. An initiative of the School of Continuing & Professional Studies, the program gives individuals with limited English proficiency the next-level English and professional skills they need to find jobs that match their talents and training.

The St. Louis Black Repertory Company will present August Wilson’s “Radio Golf,” the 10th and final play in Wilson’s monumental American Century Cycle, in WashU’s Edison Theatre May 16 through June 1, with previews May 14 and 15.

The George and Carol Bauer Leaders Academy celebrated WashU leaders and organizations making a difference on campus and in the community at the annual Excellence in Leadership Awards, held April 17 in Risa Commons.

Biologist Jonathan Losos, in Arts & Sciences, has documented evidence of a kind of “copycat” evolution between extremely short-faced breeds of cats and dogs. Generations of intentional breeding have led these animals to converge on a rounded, flat-nosed head shape that humans prefer — even though the shape causes a variety of health ailments.

The School of Law has recognized six alumni with 2025 Distinguished Alumni Awards. These annual awards honor alumni who have obtained distinction in their careers while exemplifying characteristics of leadership, commitment, courage and confidence.

Images from on and around the WashU campuses.

Night Off is exactly that — a break for parents, run by WashU student volunteers, and an opportunity for children on the autism spectrum to make new friends.

An international clinical trial co-led by WashU Medicine found that the immunotherapy drug pembrolizumab added to standard-of-care therapy improved survival for patients with locally advanced head and neck cancer. Pembrolizumab helps the patient’s own immune cells attack and kill tumor cells.